Participated · Equity · Dec 2019

Proteus Motion develops a hardware and software fitness system that uses patented strength-measurement software to guide users through 4-minute physical assessments and a resistance training experience called 3D Resistance™. The company’s systems are installed in 41 U.S. states and two Canadian territories and are used by high-profile athletes across MLB, the NBA, the NFL and professional golf. Led by founder and CEO Sam Miller, Proteus Motion plans to use new capital to expand the team, scale production capabilities and grow its software offerings. In conjunction with the financing, industry executive Paul Byrne joined the company’s board of directors. Financially, Proteus Motion announced an $8.5M Series A and has raised $17M to date. The company positions its product for elite athletic and commercial fitness markets through combined hardware and analytics. Proteus Motion is a NYC-based sports and healthtech company (formerly Boston Biomotion) that has developed patented hardware and software delivering intelligent strength training and rehabilitation via unlimited three-dimensional movements. Its system is designed to strengthen, optimize and restore sport movements, protect joints and ligaments, and enable faster recovery. The technology has gained particular traction in the pitching community for arm care, improving biomechanics, pitching velocity and rehabilitation from Tommy John surgery. Proteus’s products are used by teams in MLB, NHL and top NCAA athletic programs, as well as prominent training and rehabilitation facilities worldwide. The company offers a software subscription that lets trainees access training content, track trends and receive personalized insights, leveraging 50 million data points captured to date. Proteus plans to use new funding to develop and manufacture its software products, conduct R&D on Version 2 of the Proteus system, and grow its subscription user base.

Participated · Series A · Apr 2019

BetterPT operates a digital marketplace and healthcare technology platform connecting physical therapists (PTs), patients, and physicians, offering inbound patient management (IPM) and appointment-request functionality. Its interoperable, HIPAA-compliant application is EMR compatible and aims to improve patient access to PT and clinical rehabilitation services. The company markets itself as the fastest growing specialized PT marketplace in the U.S. and partners with Hospital for Special Surgery (HSS). BetterPT’s platform lets patients find local clinics that accept their insurance and request appointments online, while providing operational efficiencies to clinics. The company recently completed a $5 million Series A financing to support growth and broader adoption of its marketplace.

Participated · Equity · Nov 2012

Althia is a Spanish biomedical company focused on personalized predictive oncology, offering diagnostic and treatment activities for cancer patients. The company operates advanced diagnostic laboratories and translational research facilities in Barcelona and Granada and maintains offices in Madrid. Its three areas of activity are care in diagnosis/prognosis, translational research, and SD-IGRT treatment, with SD-IGRT currently being implemented. Althia will use the €3M funding to strengthen the business line and to initiate diagnostic services and treatment activity for cancer patients using single-dose image-guided radiation therapy. The company was formed in 2007 by Dr. Carlos Cordon-Cardo and Dr. Zvi Fuchs and is supported by Santiago de Torres and Isabel Lozano.